Becton, Dickinson and Company
BDX Healthcare Medical Instruments & Supplies
In the quarter to June 2026, revenue grew 5.44%, EPS fell 31.5%, free cash flow fell 31.6% and total debt fell 22.9%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for three.
Follow BDX
Becton, Dickinson and Company (BDX) Revenue growth
Becton, Dickinson and Company's revenue growth over the twelve months to 30 June 2026 was 13.1%, up 4.9 percentage points from fiscal 2025 (8.24%). Over the past ten years it has ranged from −7.03% (fiscal 2020) to 32.2% (fiscal 2018); the current reading is higher than 64% of that period. That is above the Medical Instruments & Supplies industry median of 8.85% and above the Healthcare sector median of 8.27%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 8.24% | 4.08 |
| FY2024 | 4.16% | 1.50 |
| FY2023 | 2.66% | 4.02 |
| FY2022 | −1.36% | (20.38) |
| FY2021 | 19.0% | 26.05 |
| FY2020 | −7.03% | (15.21) |
| FY2019 | 8.18% | (23.99) |
| FY2018 | 32.2% | 35.29 |
| FY2017 | −3.12% | (24.53) |
| FY2016 | 21.4% | (0.33) |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 5.44% | 0.22 |
| Mar 2026 | 5.22% | 3.59 |
| Dec 2025 | 1.63% | (35.69) |
| Sep 2025 | 37.3% | 42.61 |
| 42 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| ISRG Intuitive Surgical, Inc. compare | 20.7% |
| RGEN Repligen Corporation compare | 16.5% |
| BDX Becton, Dickinson and Company | 13.1% |
| WST West Pharmaceutical Services, Inc. compare | 12.4% |
| RMD ResMed Inc. compare | 9.85% |
| ALC Alcon compare | 8.34% |
| BAX Baxter International Inc. compare | 5.36% |
| SOLV Solventum Corporation compare | −0.93% |
| MDLN Medline Inc. compare | — |
| Medical Instruments & Supplies industry median | 8.85% |
| Healthcare sector median | 8.27% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on BDX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement